Showing 1,658 news articles about Hepatitis & HIV

Filters Content type: Editors' picks Topic: Hepatitis & HIV

Hepatitis A, B and C are viral infections that can damage the liver and cause serious illnesses. Co-infection with HIV and hepatitis B or C is quite common. Safe and effective treatments are available.

Hepatitis C symptoms & diagnosis

Gay Men Should Be Tested for Hepatitis C

Editor's pick
Huffington Post (blog)
31 October 2013
Hepatitis C treatment

UNITAID publishes first scoping report on hepatitis C

Editor's pick
UNITAID
30 October 2013
Hepatitis C transmission & prevention

Pregnancy Could Help Hepatitis C Develop Into Hardier Strain; Viruses Able To Replicate Faster Could Be Passed Down

Editor's pick
Medical Daily
30 October 2013
New & experimental hepatitis C treatment

European Medicines Agency advises on compassionate use of sofosbuvir

Editor's pick
European Medicines Agency
26 October 2013
New & experimental hepatitis C treatment

FDA panel backs Gilead hepatitis C drug sofosbuvir

Editor's pick
Reuters
26 October 2013
Hepatitis C treatment

FDA Advisory Committee Recommends Approval of Simeprevir for Combination Treatment of Genotype 1 Chronic Hepatitis C in Adult Patients

Editor's pick
Janssen press release
25 October 2013
New & experimental hepatitis C treatment

Merck Receives Breakthrough Therapy Designation for MK-5172/MK-8742, an Investigational Oral Combination Regimen for the Treatment of Chronic Hepatitis C Virus (HCV) Infection

Editor's pick
Merck press release
23 October 2013
Hepatitis B

Men-only hepatitis B mutation explains higher cancer rates

Editor's pick
Eurekalert Inf Dis
18 October 2013
The search for a cure

Bristol-Myers Squibb launches initiative to support search for cure in chronic viral diseases

Editor's pick
Bristol-Myers Squibb press release
17 October 2013
Hepatitis C treatment

The uncomfortable truth: Hepatitis C in England

Editor's pick
Hepatitis C Trust
15 October 2013
Hepatitis & HIV

Guidelines for the Management of Hepatitis Viruses in Adults Infected with HIV 2013

Editor's pick
British HIV Association
15 October 2013
Hepatitis C treatment

Hepatitis C Trust says strategy urgent as related liver disease on the rise

Editor's pick
The Guardian
14 October 2013
New & experimental hepatitis C treatment

Enter the Nonspecialist: Will Evolving Hepatitis C Therapies Reduce the Need for Specialized Care?

Editor's pick
Clinical Care Options (requires registration)
14 October 2013
New & experimental hepatitis C treatment

Interferon-free therapy alters lipid metabolism, glucose homeostasis in chronic HCV patients

Editor's pick
Healio Hepatology
14 October 2013
Hepatitis C symptoms & diagnosis

Lack of HCV Genetic Diversity Tied to Higher Liver Disease Risk in Women With HIV

Editor's pick
NATAP
12 October 2013
New & experimental hepatitis C treatment

Idenix Shares Fall as J&J Buys Rival Hepatitis C Therapy

Editor's pick
Bloomberg
8 October 2013
New & experimental hepatitis C treatment

Investigational interferon-free regimen demonstrates undetectable hepatitis C virus in all patients reaching end of treatment in ongoing Phase II trial

Editor's pick
Boehringer-Ingelheim press release
8 October 2013
New & experimental hepatitis C treatment

Janssen Acquires Investigational NS5A Inhibitor for the Treatment of Hepatitis C from GlaxoSmithKline

Editor's pick
Janssen press release
8 October 2013
Hepatitis C treatment

Health Department Announces Plan to Combat Hepatitis C

Editor's pick
New York City Department of Health and Mental Hygiene (press release)
8 October 2013
Hepatitis B

Vaccination campaign doubles HBV mutations

Editor's pick
Eurekalert Medicine & Health
8 October 2013
Hepatitis C transmission & prevention

Hepatitis C education crucial to cut high infection rate in Middle East and North Africa

Editor's pick
The National
7 October 2013
Hepatitis C symptoms & diagnosis

Canada should screen all baby boomers for hepatitis C, experts argue

Editor's pick
The Globe and Mail
1 October 2013
Hepatitis B

FDA Warns of Hepatitis B Reactivation Risk with Immune-suppressing Cancer Drugs

Editor's pick
HIVandhepatitis.com
30 September 2013
New & experimental hepatitis C treatment

Achillion's Hepatitis C Drug Still on Hold by U.S. FDA

Editor's pick
Bloomberg
30 September 2013